AXTA Strangle Strategy
AXTA (Axalta Coating Systems Ltd.), in the Basic Materials sector, (Chemicals - Specialty industry), listed on NYSE.
Axalta Coating Systems Ltd., through its subsidiaries, manufactures, markets, and distributes high-performance coatings systems in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It operates through two segments, Performance Coatings and Transportation Coatings. The company offers water and solvent-borne products and systems to repair damaged vehicles for independent body shops, multi-shop operators, and original equipment manufacturer (OEM) dealership body shops. It also provides functional and decorative liquid, and powder coatings used in various industrial applications, including architectural cladding and fittings, automotive coatings, general industrial, job coaters, energy solutions, HVAC, appliances, industrial wood, coil, and oil and gas pipelines; and coatings for building materials, cabinet, wood and luxury vinyl flooring, and furniture market under the Voltatex, AquaEC, Durapon, Hydropon, UNRIVALED, Tufcote, and Ceranamel for liquid coatings; and Alesta, Nap-Gard, Abcite, Teodur, and Plascoat brands for powder coatings. In addition, the company develops and supplies electrocoat, primer, the basecoat, and clearcoat products for OEMs of light and commercial vehicles; and coatings systems for various commercial applications, including HDT, bus, and rail under the Imron, Imron Elite, Centari, Rival, Corlar epoxy undercoats, and AquaEC brands. It also sells its product under the Audurra, Challenger, Chemophan, ColorNet, Cromax, Cromax Mosaic, Durapon 70, Duxone, Harmonized Coating Technologies, Imron ExcelPro, Lutophen, Nason, Spies Hecker, Standox, Stollaquid, Syntopal, Syrox, Raptor, U-POL, and Vermeera brand names.
AXTA (Axalta Coating Systems Ltd.) trades in the Basic Materials sector, specifically Chemicals - Specialty, with a market capitalization of approximately $5.97B, a trailing P/E of 16.16, a beta of 1.25 versus the broader market, a 52-week range of 24.937-35.72, average daily share volume of 2.6M, a public-listing history dating back to 2014, approximately 13K full-time employees. These structural characteristics shape how AXTA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.25 places AXTA roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a strangle on AXTA?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current AXTA snapshot
As of May 15, 2026, spot at $26.88, ATM IV 40.20%, IV rank 25.47%, expected move 11.53%. The strangle on AXTA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.
Why this strangle structure on AXTA specifically: AXTA IV at 40.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a AXTA strangle, with a market-implied 1-standard-deviation move of approximately 11.53% (roughly $3.10 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AXTA expiries trade a higher absolute premium for lower per-day decay. Position sizing on AXTA should anchor to the underlying notional of $26.88 per share and to the trader's directional view on AXTA stock.
AXTA strangle setup
The AXTA strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AXTA near $26.88, the first option leg uses a $28.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AXTA chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AXTA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $28.00 | $1.35 |
| Buy 1 | Put | $26.00 | $1.35 |
AXTA strangle risk and reward
- Net Premium / Debit
- -$270.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$270.00
- Breakeven(s)
- $23.30, $30.70
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
AXTA strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on AXTA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$2,329.00 |
| $5.95 | -77.9% | +$1,734.78 |
| $11.89 | -55.7% | +$1,140.56 |
| $17.84 | -33.6% | +$546.34 |
| $23.78 | -11.5% | -$47.88 |
| $29.72 | +10.6% | -$97.89 |
| $35.66 | +32.7% | +$496.33 |
| $41.61 | +54.8% | +$1,090.55 |
| $47.55 | +76.9% | +$1,684.77 |
| $53.49 | +99.0% | +$2,278.99 |
When traders use strangle on AXTA
Strangles on AXTA are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the AXTA chain.
AXTA thesis for this strangle
The market-implied 1-standard-deviation range for AXTA extends from approximately $23.78 on the downside to $29.98 on the upside. A AXTA long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current AXTA IV rank near 25.47% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AXTA at 40.20%. As a Basic Materials name, AXTA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AXTA-specific events.
AXTA strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AXTA positions also carry Basic Materials sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AXTA alongside the broader basket even when AXTA-specific fundamentals are unchanged. Always rebuild the position from current AXTA chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on AXTA?
- A strangle on AXTA is the strangle strategy applied to AXTA (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With AXTA stock trading near $26.88, the strikes shown on this page are snapped to the nearest listed AXTA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are AXTA strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the AXTA strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 40.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$270.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AXTA strangle?
- The breakeven for the AXTA strangle priced on this page is roughly $23.30 and $30.70 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AXTA market-implied 1-standard-deviation expected move is approximately 11.53%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on AXTA?
- Strangles on AXTA are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the AXTA chain.
- How does current AXTA implied volatility affect this strangle?
- AXTA ATM IV is at 40.20% with IV rank near 25.47%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.